Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon-γ synthesis and macrophage sensitivity to interferon-γ Free

Abstract

Coronavirus-free A/J mice (A/J-), in contrast to those naturally infected with coronavirus (A/J+), were shown to be susceptible to experimental infection with our strain of mouse hepatitis virus 3 (MHV3). A/J-mice experimentally hyperimmunized with inactivated MHV3 (A/Ji) became resistant to challenge with this virus. BALB/c mice free of (BALB/c-) or naturally infected with (BALB/c+) coronavirus, or hyperimmunized with inactivated MHV3 (BALB/ci), were always fully susceptible. All susceptible mice developed an acute hepatitis with a high virus titre in the tissues. Resistance mice developed a mile disease in which the low virus titres detected in the tissues were cleared. After infection, interferon (IFN)-γ synthesis in A/J-mice was lower than that in A/J+ and A/Ji mice; IFN-γ synthesis was very high in BALB/c+ and BALB/ci mice, but low in BALB/c-mice. Studies of the anti-MHV3 effect induced in macrophages showed that only IFN-γ-activated A/J mouse macrophages were able to restrict partially the growth of MHV3, regardless of whether the animals had been immunized. The effect occurred only when the cells were activated with IFN-γ before virus infection. The results indicate that the resistance of A/J mice to our strain of MHV3 is not natural but is acquired after immunization, and that the mechanism involved is dependent on T cell activity, IFN-γ production and the sensitivity of macrophages to IFN-γ.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-6-1317
1991-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/6/JV0720061317.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-6-1317&mimeType=html&fmt=ahah

References

  1. Andreesen R., Picht J., Lohr G. N. 1983; Primary cultures of human blood-borne macrophages grown on hydrophobic Teflon membranes. Journal of Immunological Methods 56:295–304
    [Google Scholar]
  2. Arnheiter H., Baechi T., Haller O. 1982; Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. Journal of Immunology 129:1275–1281
    [Google Scholar]
  3. Bailey O. T., Pappenheimer A. M., Cheever F. S., Daniels J. B. 1949; A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. Journal of Experimental Medicine 90:195–212
    [Google Scholar]
  4. Buchmeier M. J., Lewicki M. A., Talbot P. J., Knobler R. L. 1984; Murine hepatitis virus 4 (strain JHM) induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261–267
    [Google Scholar]
  5. Cheever F. S., Muller J. H. 1947; Epidemic diarrheal disease in suckling mice. I. Manifestations, epidemiology and attempts to transmit the disease. Journal of Experimental Medicine 85:405–416
    [Google Scholar]
  6. Dick G. N. A., Niven J. S. F., Gledhill A. N. 1956; A virus related to that causing hepatitis in mice (MHV). British Journal of Experimental Pathology 37:90–98
    [Google Scholar]
  7. Dindzanz V. J., Skamene E., Levy G. A. 1986; Susceptibility: resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are linked and controlled by two non-H-2 linked genes. Journal of Immunology 137:2355–2362
    [Google Scholar]
  8. Dupuy J. M., Dupuy C., Decarie D. 1984; Genetically determined resistance to mouse hepatitis virus type 3 is expressed in hematopoietic donor cells in radiation chimeras. Journal of Immunology 133:1609–1615
    [Google Scholar]
  9. Hierholzer J. C., Broderson J. R., Murphy F. A. 1979; New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infection and Immunity 24:508–522
    [Google Scholar]
  10. Keck J. G., Sue L. H., Makino S., Stohlman S. A. 1988; RNA recombination of murine corona viruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. Journal of Virology 62:1989–1998
    [Google Scholar]
  11. Kraft L. M. 1966; Epizootic diarrhea of infant mice and lethal intestinal virus infection of infant mice. National Cancer Institute Monographs 20:55–61
    [Google Scholar]
  12. Leibowitz J. L., Fung L. S., Levy G. A. 1983; A sensitive radioimmunoassay for the determination of antibodies to mouse hepatitis virus. Journal of Virological Methods 3:255–261
    [Google Scholar]
  13. Le Prevost C., Levy-Leblond E., Virelizier J. L., Dupuy J. M. 1975; Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanisms. Journal of Immunology 114:221–227
    [Google Scholar]
  14. Levy G. A., Leibowitz J. L., Edgington T. S. 1981; Induction of monocyte procoagulant activity by murine hepatitis virus type 3 (MHV3) parallels disease susceptibility in mice. Journal of Experimental Medicine 154:1150–1157
    [Google Scholar]
  15. Lucchiari M. A., Pereira C. A. 1989; A major role of macrophage activation by interferon gamma during mouse hepatitis virus type 3 infection. I. Genetically dependent resistance. Immunobiology 180:12–22
    [Google Scholar]
  16. Lucchiari M. A., Pereira C. A. 1990; A major role of macrophage activation by interferon gamma during mouse hepatitis virus type 3 infection. II. Age dependent resistance. Immunobiology 181:31–39
    [Google Scholar]
  17. McIntosh K. 1985; Coronaviruses. In Virology pp 1323–1330 Edited by Fields B. N. New York: Raven Press;
    [Google Scholar]
  18. Makino S., Fleming J. O., Keck J. G., Stohlman S. A., Lai M. M. C. 1987; RNA recombination of coronavirus: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl-terminal of peplomers. Proceedings of the National Academy of Sciences, U.S.A 84:6567–6571
    [Google Scholar]
  19. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  20. Martin J. P., Koehren F., Rannou J. J., Kirn A. 1988; Temperature sensitive mutants of mouse hepatitis virus type 3 (MHV3): isolation, biochemical and genetic characterization. Archives of Virology 100:147–160
    [Google Scholar]
  21. Martin J. P., Bingen A., Koehren F., Gut J. P., Kirn A. 1991; Altered pathogenicity in the liver induced by a mouse hepatitis virus type 3 thermosensitive mutant. Journal of Hepatology (in press)
    [Google Scholar]
  22. Munder P. G., Modolell M. 1971; Cell propagation on films of polymeric fluorocarbon as a means to regulate pericellular pH and p02 in cultured monolayers. FEBS Letters 15:191–196
    [Google Scholar]
  23. Pappenheimer A. M., Enders J. F. 1947; An epidemic diarrheal disease of suckling mice. II. Inclusions in the intestinal epithelial cells. Journal of Experimental Medicine 85:417–422
    [Google Scholar]
  24. Pereira C. A., Steffan A.-M., Kirn A. 1984a; Interaction between mouse hepatitis viruses and primary cultures of Kupffer and endothelial liver cells from resistant and susceptible inbred mouse strains. Journal of General Virology 65:1617–1620
    [Google Scholar]
  25. Pereira C. A., Mercier G., Oth D., Dupuy J. M. 1984b; Induction of natural killer cells and interferon during mouse hepatitis virus infection of resistant and susceptible inbred mouse strains. Immunobiology 166:35–42
    [Google Scholar]
  26. Rowe W. P., Hartley J. W., Capps W. I. 1963; Mouse hepatitis virus infection as a highly contagious, prevalent, enteric infection in mice. Proceedings of the Society for Experimental Biology and Medicine 112:161–165
    [Google Scholar]
  27. Slade S. J., Langhorne J. 1989; Production of interferon gamma during infection of mice with Plasmodium chabaudi chaubaudi . Immunobiology 179:353–359
    [Google Scholar]
  28. Syverton J. T., Olitsky P. K. 1934; Bacteriological studies on an epizootic of intestinal disease in suckling and newly weaned mice. Journal of Experimental Medicine 60:385–394
    [Google Scholar]
  29. Van der Riet F. S. J., Kahn L. B. 1973; Isolation of a murine hepatitis virus from Swiss mice treated with antilymphocyte serum. Archiv fur die gesamte Virusforschung 42:1–8
    [Google Scholar]
  30. Virelizier J. L., Gresser I. 1978; Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. Journal of Immunology 120:1616–1619
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-6-1317
Loading
/content/journal/jgv/10.1099/0022-1317-72-6-1317
Loading

Data & Media loading...

Most cited Most Cited RSS feed